A daily treat can become part of a dog’s routine very quickly. That makes the ingredients in the treat worth examining, especially when the product contains a cannabinoid such as cannabidiol, or CBD. Pet owners may see these products marketed around calm behavior, mobility, comfort, or general wellness, but each claim needs to be considered separately from what scientific studies have actually established.
Holistapet CBD Dog Treats are typically chewable products containing a stated amount of cannabidiol. They may be made with oils, meat flavors, plant ingredients, vitamins, or other compounds intended to make the treat appealing to dogs. The convenience of a premeasured chew can make administration easier, but convenience does not remove the need to check concentration, ingredients, testing, and potential interactions.
What Everyday Wellness Really Means
Canine wellness covers ordinary areas of health such as nutrition, physical activity, body condition, dental care, preventive veterinary visits, parasite control, and appropriate mental stimulation. A supplement fits into that picture only when its use is appropriate for the individual animal.
CBD should therefore be considered separately from basic care. A dog still needs a nutritionally appropriate diet, clean water, exercise suited to its age and condition, routine veterinary attention, and a safe environment.
A supplement cannot compensate for an untreated medical problem. If a dog suddenly stops eating, becomes unusually tired, develops persistent diarrhea, has difficulty walking, or shows a significant behavior change, the cause deserves veterinary assessment rather than simply adding a new treat.
The Difference Between Routine and Treatment
A wellness product and a medical treatment can sound similar in advertising, but the distinction matters.
A product described as supporting normal daily behavior may be presented differently from one that claims to treat anxiety, arthritis, seizures, inflammation, or another disease. Medical claims require stronger evidence than a general description of a product’s ingredients.
The U.S. Food and Drug Administration states that it has not approved cannabis for use in animals and cannot ensure the safety or effectiveness of cannabis products marketed for animals. The agency also states that CBD is not approved for use as an ingredient in animal food.
That information is particularly relevant when evaluating products sold online. Availability does not establish veterinary approval, effectiveness, or a standardized dose.
Looking Beyond the Word “Hemp”
Hemp appears on many pet product labels, but the term alone does not describe the cannabinoid profile of a product.
Hemp refers to cannabis plants cultivated under particular legal definitions, including limits on THC concentration in U.S. federal law. A finished product can contain different cannabinoids depending on the plant material and extraction method.
A label should make it possible to determine whether the product contains CBD, how much CBD is supplied, and whether THC is present.
This is especially important because dogs can experience adverse effects from cannabis exposure. The FDA lists possible signs after cannabis ingestion in pets, including lethargy, depression, excessive drooling, vomiting, agitation, tremors, and convulsions.
A treat intended for a dog should never be confused with a human cannabis edible. Human products may contain much higher cannabinoid concentrations or additional ingredients that are unsuitable for animals.
Read the Serving Information Carefully
The total CBD listed on a package is not necessarily the amount contained in one treat.
For example, a package could contain 600 milligrams of CBD across 30 treats. If the CBD were evenly distributed, that would equal 20 milligrams per treat. Another package might contain the same number of treats but only 300 milligrams total, resulting in 10 milligrams per piece.
This simple calculation can prevent confusion when comparing products.
The following information is useful when examining a label:
- CBD concentration per treat
- Total CBD in the package
- Number of treats
- THC concentration, if applicable
- Complete ingredient list
- Feeding directions
- Lot or batch identification
- Expiration date
- Manufacturer information
- Laboratory testing information
A product that gives only a broad statement such as “hemp infused” provides less information than a product that identifies the cannabinoid concentration precisely.
What Research Can and Cannot Tell Pet Owners
Scientific research into CBD and dogs has increased, although the evidence remains limited in several areas.
One frequently cited study examined dogs with osteoarthritis. Published in Frontiers in Veterinary Science in 2018, the randomized, placebo-controlled crossover study involved 16 dogs. Researchers reported reductions in certain pain scores and increases in activity during the CBD treatment period. The study also recorded an increase in alkaline phosphatase, a liver-associated enzyme, during treatment.
Those findings are useful, but they should be interpreted within the study’s limits. Sixteen dogs is a small sample, and the research involved a particular CBD oil, a particular dosing protocol, and dogs with osteoarthritis. Results from that study cannot automatically establish that a commercial chew will produce the same response in a healthy dog.
Research design also matters. Laboratory findings, animal studies, observational reports, and controlled clinical trials provide different levels of evidence.
A product can contain a scientifically studied ingredient while the finished product itself has not been studied in the same way.
Why Product Form Matters
CBD oil and CBD treats are not necessarily interchangeable.
An oil can be measured by volume and may allow adjustments in the amount administered. A treat provides a fixed quantity per piece, assuming the product is manufactured consistently.
The ingredients surrounding CBD can also differ. Oils may use carrier oils, while treats can contain proteins, grains, starches, fats, flavoring agents, or other supplements.
Absorption can vary according to formulation and whether the product is administered with food. Research into canine CBD pharmacokinetics has found measurable differences in how cannabidiol is handled by the body, which is one reason researchers continue studying appropriate formulations and dosing schedules.
Building a More Careful Daily Routine
If a veterinarian agrees that a CBD product is reasonable to consider, introducing it as part of an organized routine can make observations easier.
A dog should not receive several new supplements at once. If a new CBD treat, vitamin, digestive supplement, and dietary change are introduced on the same day, an adverse reaction becomes difficult to trace.
One product at a time creates a clearer record.
A simple routine can include:
- Record the product name and concentration.
- Follow the amount recommended by the veterinarian or product directions.
- Give the treat at a consistent time if advised.
- Observe appetite, energy, stool, coordination, and general behavior.
- Record unusual changes.
- Report concerning reactions to a veterinary professional.
This approach is more useful than judging effectiveness after a single serving.
Dogs Have Different Starting Points
A healthy young dog and an older dog with several medications should not be treated as equivalent simply because they weigh the same.
Age can affect metabolism and overall health. Existing liver problems may influence how substances are processed. Prescription medications can create interaction concerns. A dog with a history of digestive sensitivity may also react differently to the additional ingredients in a chew.
Weight is therefore only one part of the picture.
Veterinary guidance becomes especially relevant when a dog is receiving medication for pain, seizures, heart conditions, allergies, or other chronic problems. CBD can influence metabolic pathways involved in processing certain substances, so combining products without professional review can create avoidable uncertainty.
Quality Testing Deserves Attention
CBD products can differ in cannabinoid concentration even when their labels appear similar.
The FDA has reported concerns about the accuracy of CBD product labeling and has found products that did not contain the CBD levels claimed on their labels. The agency has also investigated concerns involving contaminants such as pesticides, heavy metals, and THC.
Independent laboratory testing can provide additional information about a finished product.
A useful laboratory report may identify the concentrations of cannabinoids and provide screening results for contaminants. The report should ideally correspond to the product’s current lot or batch.
Testing does not guarantee that a product is appropriate for every dog. It does provide information that cannot be obtained from packaging alone.
Ingredient Lists Still Matter
A laboratory report cannot replace an ingredient list.
A dog may react to a flavoring ingredient, protein source, preservative, or other component rather than CBD itself. Dogs with known food sensitivities require particular attention to the complete formulation.
Treats should also be kept separate from human snacks. A family member may assume that a chew is an ordinary dog treat, while another person may know it contains a concentrated cannabinoid.
Clear storage helps prevent mistakes.
When a Daily Treat Should Be Reconsidered
A new supplement deserves closer attention if a dog develops unusual symptoms after receiving it.
Potential warning signs can include marked sleepiness, weakness, vomiting, diarrhea, tremors, loss of coordination, excessive drooling, or abnormal behavior. The severity and combination of symptoms matter, particularly when a product contains THC.
Accidental ingestion should be handled differently from routine administration. If a dog consumes an unknown or excessive amount, the package should be kept available so a veterinary professional can identify the product and its concentration.
The FDA specifically advises contacting a veterinarian, animal emergency hospital, or animal poison control center when there are concerns about adverse effects from cannabis exposure.
A Practical Way to Evaluate Wellness Claims
Before accepting a claim on a package or website, consider what kind of statement it actually makes.
“Contains CBD” is a statement about ingredients.
“Supports normal daily wellness” is a broad product description.
“Treats arthritis” is a medical claim that requires evidence for that specific use.
These statements should not be treated as equivalent.
Research involving osteoarthritis provides some evidence worth studying, but it does not establish that CBD prevents arthritis, cures joint disease, or replaces veterinary treatment. The same principle applies to claims involving anxiety, seizures, cancer, digestive conditions, and other diseases.
A careful reader should ask whether the claim has been tested in dogs, whether the study involved the same formulation, how many animals participated, and whether the findings have been reproduced.
Final Thoughts
CBD can be considered within the broader conversation about canine supplements, but evidence, product quality, and individual health circumstances should guide the decision. A consistent routine, careful label review, independent testing, secure storage, and veterinary input provide a more responsible framework for evaluating cannabinoid treats.